Exact Mass: 367.1701

N-Allylsecoboldine

3,5-dimethoxy-8-{2-[methyl(prop-2-en-1-yl)amino]ethyl}phenanthrene-2,6-diol

Prucalopride

4-Amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboximidate

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D005765 - Gastrointestinal Agents > D054368 - Laxatives Prucalopride is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer[1][2][3].

Pyrazoloacridine

(3-{4-methoxy-10-nitro-8,14,15-triazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-14-yl}propyl)dimethylamine

C19H21N5O3 (367.1644)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000970 - Antineoplastic Agents

4-[[1-(4-Tert-Butylphenyl)-5-oxo-3-pyrrolidinyl]methoxy]benzoic acid

4-{[1-(4-tert-butylphenyl)-5-oxopyrrolidin-3-yl]methoxy}benzoic acid

A pyrrolizine alkaloid that is jacobine in which the tertiary amino function has been oxidised to the corresponding N-oxide. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2257 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 179 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 169 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 159 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 149 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 139 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 129 INTERNAL_ID 129; CONFIDENCE Reference Standard (Level 1) CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 119 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 109

6-benzoyloxy-2-(hydroxy-phenyl-methyl)-8-methyl-nortropan-3-ol

3alpha-(3,4,5-trimethoxybenzoyloxy)tropan-6beta,7beta-diol|3alpha-(3,4,5-trimethoxybenzoyloxy)tropan-6beta,7beta-diol|Tropane-3alpha,6beta,7beta-triol 3-(3,4,5-trimethoxybenzoate)

Q63399172

marmesiline|N-[2-hydroxy-2-[4-[(2-hydroxy-3-methyl-3-butenyl)oxy]phenyl]ethyl]-3-phenyl-(2E)-2-propenamide

daphnicyclidin A

Otosenin

Val Tyr Ser

Thr Thr Phe

Val Ser Tyr

Thr Phe Thr

Ser Val Tyr

Tyr Val Ser

Phe Thr Thr

SCHEMBL3193422

Ser Tyr Val

Isatidine

[1,6]Dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6-(hydroxymethyl)-5-methyl-, 12-oxide, (3Z,5R,6S,14aR,14bR)-; Isatidine (6CI,7CI); Retrorsine, N-oxide (8CI); Senecionan-11,16-dione, 12,18-dihydroxy-, 4-oxide; Retrorsine oxide

Isatidine is a citraconoyl group.

RET-NO

(1R,4Z,6S,7S,17R)-4-Ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methyl-14-oxido-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

Usaramine N-oxide, a alkaloid isolated from Crotalaria pallida, possesses anti-inflammatory activities[1].

Jacobine N-oxide

(1R,3S,6R,7R,17R)-7-hydroxy-3,6,7-trimethyl-14-oxidospiro[2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-4,2-oxirane]-3,8-dione

1,2,9,10-tetramethoxy-6,7-dimethyl-5,6-dihydro-4H-dibenzo[de,g]quinoline

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.137 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.143

Retrorsine N-oxide

CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2284

Tyr Ser Val

Lys-Leu-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-5-methylhexanoic acid

Lys-Ile-OH

(2S,4S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-4-methylhexanoic acid

Leu-Lys-OH

(S)-7-amino-2-(3-isobutoxy-4-nitrobenzamido)heptanoic acid

Ile-Lys-OH

(S)-7-amino-2-(3-((S)-sec-butoxy)-4-nitrobenzamido)heptanoic acid

Fmoc-7-Ahp-OH

Dimoxyline

1-[(4-ethoxy-3-methoxyphenyl)methyl]-6,7-dimethoxy-3-methylisoquinoline

C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

3-(3-N-BOC-AMINO-PYRROLIDIN-1-YL)-1-(6-CHLORO-PYRIDIN-3-YL)-2-METHYL-PROPAN-1-ONE

1-(6-CHLORO-PYRIDIN-3-YL)-2-METHYL-3-(4-BOC-PIPERAZIN-1-YL)-PROPAN-1-ONE

1-(6-CHLORO-PYRIDIN-3-YL)-3-(4-BOC-PIPERAZIN-1-YL)-BUTAN-1-ONE

Fmoc-N-Me-Leu-OH

5-(4-(Methylsulfonyl)piperazin-1-yl)pyridine-3-boronic acid pinacol ester

C16H26BN3O4S (367.1737)

benzyl(triphenyl)phosphanium,boranuide

C25H25BP (367.1787)

Fmoc-β-Homo-Leu-OH

3-[benzyl(propan-2-yl)amino]-1-naphthalen-2-ylpropan-1-one,hydrochloride

C23H26ClNO (367.1703)

Fmoc-Neopentylglycine

Fmoc-N-Me-Ile-OH

Fmoc-N-Methyl-D-leucine

Pramiracetam sulfate

C14H29N3O6S (367.1777)

C26170 - Protective Agent > C1509 - Neuroprotective Agent

(R)-N-FMoc-α-Methylleucine

Fmoc-HomoLeu-OH

(S)-N,N-DIMETHYL-8,9,10,11,12,13,14,15-OCTAHYDRODINAPHTHO[2,1-D:1,2-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE

C22H26NO2P (367.1701)

ZM 39923 HCl

C23H26ClNO (367.1703)

2-[[5-(DIBUTYLAMINO)-2-THIENYL]METHYLENE]-1H-INDENE-1,3(2H)-DIONE

C22H25NO2S (367.1606)

Fmoc-β-homoisoleucine

Pitofenone

pitofenone hcl

C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

3-(9H-fluoren-9-ylmethoxycarbonylamino)heptanoic acid

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-leucine

Benzoicacid, 2-[4-(cyclohexylethylamino)-2-hydroxybenzoyl]-

Fmoc-D-Homoleucine

Tyroservaltide

prucalopride

(3E)-3-[(2E,4E,6E)-1-hydroxy-8-methyldeca-2,4,6-trienylidene]-5-[(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione

5-(3-Methylbenzylidene)-2-[(1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene)hydrazono]-1,3-thiazolidin-4-one

C21H25N3OS (367.1718)

7-(diethylamino)-N-[(4-fluorophenyl)methyl]-2-imino-1-benzopyran-3-carboxamide

C21H22FN3O2 (367.1696)

3-[(4-Ethoxycarbonyl-4-phenyl-1-piperidinyl)methyl]benzoic acid

N-[5-ethyl-1-(2-morpholin-4-ylethyl)-2-oxo-3H-indol-3-yl]acetamide;hydrochloride

[1-(2,1,3-Benzothiadiazol-5-ylmethyl)-4-(2-phenylethyl)-4-piperidinyl]methanol

C21H25N3OS (367.1718)

(2S,3S,4S)-2-cyano-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H22FN3O2 (367.1696)

Usaramine N-oxide